Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Apr;4(2):182-91.
doi: 10.1007/s12265-010-9249-8. Epub 2011 Jan 7.

Bone marrow cell injection for chronic myocardial ischemia: the past and the future

Jan van Ramshorst  1 , Sander F Rodrigo, Martin J Schalij, Saskia L M A Beeres, Jeroen J Bax, Douwe E Atsma
Affiliations
Review

Bone marrow cell injection for chronic myocardial ischemia: the past and the future

Jan van Ramshorst et al. J Cardiovasc Transl Res. 2011 Apr.

Abstract

Intramyocardial bone marrow cell injection is currently being investigated as a new therapeutic option for the treatment of chronic myocardial ischemia. Experimental studies and early phase clinical trials established a favorable safety profile of this approach and suggested that bone marrow cell injection was associated with clinical and functional improvements. Recently, a randomized, double-blind, placebo-controlled trial demonstrated that intramyocardial bone marrow cell injection was associated with beneficial effects on myocardial perfusion and anginal symptoms. However, the mechanisms by which bone marrow cells may improve myocardial perfusion are only partially understood, and several issues remain to be addressed. This review aims to provide a summary of the current experience with bone marrow cell therapy as a novel treatment option for patients with chronic myocardial ischemia. Therefore, the most frequently used cell types will be reviewed along with the mechanisms through which bone marrow cells may improve myocardial perfusion and function. In addition, possible routes of delivery are compared, and the results of currently available experimental and clinical studies are discussed.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Potential mechanisms by which bone marrow cells may improve myocardial perfusion and anginal symptoms
Fig. 2
Fig. 2
SPECT images (horizontal short-axis projections) from a representative patient from the study of van Ramshorst et al. 99mTc-Tetrofosmin SPECT shows stress-induced ischemia at baseline in the inferior wall (arrowheads). At 3 months follow-up, the ischemia in the inferior wall has resolved
See this image and copyright information in PMC

References

    1. Yang EH, Barsness GW, Gersh BJ, Chandrasekaran K, Lerman A. Current and future treatment strategies for refractory angina. Mayo Clinic Proceedings. 2004;79:1284–1292. doi: 10.4065/79.10.1284. - DOI - PubMed
    1. van Ramshorst J, Bax JJ, Beeres SL, Dibbets-Schneider P, Roes SD, Stokkel MP, de Roos A, Fibbe WE, Zwaginga JJ, Boersma E, Schalij MJ, Atsma DE. Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial. Journal of American Medical Association. 2009;301:1997–2004. doi: 10.1001/jama.2009.685. - DOI - PubMed
    1. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, et al. Bone marrow cells regenerate infarcted myocardium. Nature. 2001;410:701–705. doi: 10.1038/35070587. - DOI - PubMed
    1. Balsam LB, Wagers AJ, Christensen JL, Kofidis T, Weissman IL, Robbins RC. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature. 2004;428:668–673. doi: 10.1038/nature02460. - DOI - PubMed
    1. Murry CE, Soonpaa MH, Reinecke H, Nakajima H, Nakajima HO, Rubart M, et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature. 2004;428:664–668. doi: 10.1038/nature02446. - DOI - PubMed